- Home
- PPL vs GH Comparison
PPL vs GH Comparison
Compare PPL & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PPL | GH |
|---|---|---|
| Founded | 1920 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical Specialities |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4B | 22.9B |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PPL | GH |
|---|---|---|
| Price | $35.16 | $158.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 26 |
| Target Price | $39.81 | ★ $201.64 |
| AVG Volume (30 Days) | ★ 6.4M | 1.8M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | ★ 32.50 | 6.74 |
| EPS | ★ 1.59 | N/A |
| Revenue | ★ $9,042,000,000.00 | $982,021,000.00 |
| Revenue This Year | $6.69 | $38.42 |
| Revenue Next Year | $5.81 | $35.13 |
| P/E Ratio | $21.69 | ★ N/A |
| Revenue Growth | 6.85 | ★ 32.88 |
| 52 Week Low | $31.56 | $65.96 |
| 52 Week High | $40.11 | $191.05 |
Technical Indicators
Market Signals| Indicator | PPL | GH |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 38.93 |
| Support Level | $34.49 | $153.88 |
| Resistance Level | $36.80 | $173.94 |
| Average True Range (ATR) | 0.51 | 8.16 |
| MACD | 0.28 | -2.16 |
| Stochastic Oscillator | 97.08 | 1.83 |
Price Performance
Historical ComparisonAbout PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.